Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Stent prices to be...

    Stent prices to be fixed in 10 to 15 days: Ananth Kumar

    Written by savita thakur thakur Published On 2017-01-20T11:21:57+05:30  |  Updated On 20 Jan 2017 11:21 AM IST
    Stent prices to be fixed in 10 to 15 days: Ananth Kumar

    New Delhi: With an aim of providing relief to heart patients, the government said it will fix prices of stents in the next 10-15 days.


    Chemicals and Fertilizers Minister Ananth Kumar said that drug price regulator National Pharmaceuticals Pricing Authority (NPPA) has already been asked to take up the matter.


    "We have asked NPPA to fix prices of stents. This issue is pending for long. The price will be fixed in the next 10 to 15 days. This will give huge relief to patients," Kumar said here.


    He was speaking on the sidelines of signing of an MoU between Bureau of Pharma PSUs of India (BPPI) and National Yuva Co-operative Society for opening of 1,000 Jan Aushadhi drug stores across India.


    The NPPA has already asked manufacturers and marketers of the medical device to disclose detailed pricing data and information by the end of this month.


    It has also called for a meeting with the stakeholders to discuss the issue on January 24.


    Last year in July, the Ministry of Health had included stents in the National List of Essential Medicines, whereby the device came under purview of price control of the government.


    The step was taken as it was felt that the margin for hospitals in terms of MRP of the stents was too high. The government based its decision on a sub-committee report that recommended putting all types of stents into the list.


    Industry players had, however, criticised the move. Medical devices sector body AdvaMed and industry chamber CII said the step would not help improve access to medical devices for patients as it will not impact the overall procedure cost.


    When asked if the role of NPPA would be changed as was speculated, Kumar replied in the negative and said its mandate is to regulate drug prices and would continue to do so.

    Ananth KumarMinistry of HealthNational Pharmaceuticals Pricing AuthorityNPPAprices Ceilingstent pricesstent prices in india
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok